BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2026 8:32:54 AM | Browse: 42 | Download: 77
 |
Received |
|
2025-10-09 17:32 |
|
Peer-Review Started |
|
2025-10-09 17:32 |
|
First Decision by Editorial Office Director |
|
2025-10-28 09:46 |
|
Return for Revision |
|
2025-10-28 09:46 |
|
Revised |
|
2025-11-01 03:45 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-23 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-23 03:10 |
|
Articles in Press |
|
2025-12-23 03:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-13 03:59 |
|
Publish the Manuscript Online |
|
2026-02-28 08:32 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Critical Commentary on Initial Lurasidone Dosing Strategies in Acute Schizophrenia
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao-Yu Xing and Juan Yan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Juan Yan, Manager, MD, Professor, Graduate School, Zhejiang Chinese Medical University, No. 305 Tianmushan Road, Xihu District, Hangzhou 311402, Zhejiang Province, China. 294162939@qq.com |
| Key Words |
Lurasidone; Schizophrenia; Initial dose; Safety; Efficacy; Pragmatic trial |
| Core Tip |
Liu et al provide evidence challenging the conventional "start low, go slow" approach for lurasidone in acute schizophrenia. Their trial suggests that initiating treatment at 80 mg/day is as safe as 40 mg/day, and may offer faster symptom control. This commentary discusses these findings in the context of prior dosing studies, emphasizing the need for tailored strategies while noting methodological constraints. |
| Publish Date |
2026-02-28 08:32 |
| Citation |
Xing HY, Yan J. Critical Commentary on Initial Lurasidone Dosing Strategies in Acute Schizophrenia. World J Psychiatry 2026; 16(3): 114882 |
| URL |
https://www.wjgnet.com/2220-3206/full/v16/i3/114882.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v16.i3.114882 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
